QIAENSEMBLE
DEAD

Serial Number

77679069

Owner

QIAGEN GAITHERSBURG, INC.

Attorney

VALERIE WALSH JOHNSON

Filing Date

Feb 26, 2009

Add to watchlist:

No watchlists yet
View on USPTO

QIAENSEMBLE Trademark

Serial Number: 77679069

QIAENSEMBLE is a trademark filed by QIAGEN GAITHERSBURG, INC. on February 26, 2009. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). The application is currently no longer active.

Owner Contact Info

QIAGEN GAITHERSBURG, INC. (23 trademarks)

1201 CLOPPER ROAD
GAITHERSBURG, MD 20878

Entity Type: 03

Trademark Details

Filing Date

February 26, 2009

Registration Date

Not Registered

Published for Opposition

January 19, 2010

Goods & Services

Scientific apparatus, instruments and equipment for research and examination purposes, namely, columns for detecting nucleic acids, enzymes, and small molecules; automated laboratory equipment, namely, add-ons therefor, namely, preprogrammed smart cards for DNA purification protocols; laboratory equipment, namely, microplates, pipettes, pipette tips and pipette tip holders, sample containers, reagent holders, flasks, reagent tube holders, holders for micro containers, magnetic syringes, biochips for the purpose of screening large numbers of biological analytes, thermocyclers for the purpose of performing polymerase chain reactions or isothermal amplifications, homogenizers for the purpose of breaking up cell membranes and mixing the resulting liquids, all of the aforementioned being included in this class and being for scientific research and examination purposes

Products for medical and veterinary medical purposes, namely, diagnostic preparations in the nature of nucleic acids, enzymes, polymerases, reagents for staining and marking, molecular probes, buffer chemicals and aqueous and non-aqueous solutions of primary, secondary and tertiary alcohols and salts, distilled and purified water, magnetic particles in fluid form, and diagnostic materials for columns, all for the purpose of purification, lysis, modification and manipulation of cells, as well as for the performance of marking, separation, isolation, purification, amplification and analysis of enzymes, proteins, macro molecules and biologically active substances for separation, analysis and purification of biological and biochemical compounds, all of the foregoing for medical and veterinary purposes; Products for medical and veterinary medical purposes, namely, chemical, biochemical and biotechnological products in the nature of reagents and solvents used for sample preparation, purification, lysis, modification and manipulation of cells, as well as for the performance of marking, separation, isolation, purification, amplification and analysis of nucleic acids for medical and veterinary medical purposes, enzymes, natural and artificial proteins, macro molecules, and biologically active substances for detecting pathogens, extracting genetic information and diagnosing conditions of the human body; Kits for medical and veterinary purposes comprised of chemical, biochemical and biotechnological products in the nature of reagents and solvents, all being used for sample preparation, purification, lysis, modification and manipulation of cells, as well as for the performance of marking, separation, isolation, purification, amplification and analysis of nucleic acids for medical and veterinary medical purposes, enzymes, natural and artificial proteins, macro molecules, and biologically active substances for detecting pathogens, extracting genetic information and diagnosing conditions of the human body

Chemical, biochemical and biotechnological products for industrial and scientific purposes, in particular nucleic acids, enzymes, polymerases, reagents for staining and marking, molecular probes, buffer, aqueous and non-aqueous solutions of alcohols and salts, distilled and purified water, silica in powdered, granulate and gel form and magnetic particles in fluid form, none of the foregoing for medical or veterinary purposes; materials for columns in the nature of reagents and solvents for the purpose of sample preparation, purification, lysis, modification and manipulation of cells, none of the foregoing for medical or veterinary purposes; materials for columns in the nature of reagents and solvents for the marking, separation, isolation, purification, amplification and analysis of nucleic acids, enzymes, proteins, macro molecules and biologically active substances for separation, analysis and purification of biological and biochemical compounds, none of the foregoing for medical or veterinary purposes; kits comprising chemical, biochemical and biotechnological materials for columns in the nature of reagents and solvents for sample preparation, purification, lysis, modification and manipulation of cells as well as for the marking, separation, isolation, purification, amplification, and analysis of nucleic acids, enzymes, proteins, macro molecules and biologically active substances, none of the foregoing for medical or veterinary purposes

Medical instruments for use in diagnosis and screening with reagants for sexually transmitted diseases, diseases caused by viruses, bacteria or fungi, diseases caused by bacteria with resistance to antibiotics

Filing History

ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
May 13, 2013 MAB6
ABANDONMENT - NO USE STATEMENT FILED
May 13, 2013 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 27, 2012 EXRA
SOU EXTENSION 5 GRANTED
Sep 26, 2012 EX5G
CORRECTED NOA E-MAILED
Sep 25, 2012 NOAC
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 25, 2012 EXRA
SOU EXTENSION 5 FILED
Sep 24, 2012 EXT5
SOU TEAS EXTENSION RECEIVED
Sep 24, 2012 EEXT
SOU EXTENSION 4 GRANTED
Sep 22, 2012 EX4G
DIVISIONAL PROCESSING COMPLETE
Sep 22, 2012 DPCC
REVIEW OF CORRESPONDENCE COMPLETE
Sep 22, 2012 CORV
AMENDMENT AFTER NOA NOT ENTERED
Sep 17, 2012 INOA
DIVISIONAL REQUEST RECEIVED
Sep 17, 2012 DRRR
FAX RECEIVED
Sep 17, 2012 FAXX
FAX RECEIVED
Sep 14, 2012 FAXX
FAX RECEIVED
Sep 14, 2012 FAXX
RESPONSE TO ITU OFFICE ACTION ENTERED
Aug 24, 2012 IROA
FAX RECEIVED
Aug 24, 2012 FAXX
ITU OFFICE ACTION ISSUED FOR DIVISIONAL REQUEST
Aug 10, 2012 INCD
RESPONSE TO ITU OFFICE ACTION ENTERED
Jun 22, 2012 IROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 22, 2012 TROA
ITU OFFICE ACTION ISSUED FOR DIVISIONAL REQUEST
Jun 6, 2012 INCD
SOU EXTENSION 4 FILED
Apr 4, 2012 EXT4
SOU TEAS EXTENSION RECEIVED
Apr 4, 2012 EEXT
TEAS REQUEST TO DIVIDE RECEIVED
Apr 4, 2012 ERTD
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 15, 2011 EXRA
SOU EXTENSION 3 GRANTED
Sep 14, 2011 EX3G
SOU EXTENSION 3 FILED
Sep 13, 2011 EXT3
SOU TEAS EXTENSION RECEIVED
Sep 13, 2011 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 15, 2011 EXRA
SOU EXTENSION 2 GRANTED
Mar 14, 2011 EX2G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Mar 14, 2011 AITU
SOU EXTENSION 2 FILED
Mar 8, 2011 EXT2
SOU TEAS EXTENSION RECEIVED
Mar 8, 2011 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 2, 2010 EXRA
SOU EXTENSION 1 GRANTED
Sep 30, 2010 EX1G
SOU EXTENSION 1 FILED
Sep 30, 2010 EXT1
SOU TEAS EXTENSION RECEIVED
Sep 30, 2010 EEXT
NOA MAILED - SOU REQUIRED FROM APPLICANT
Apr 13, 2010 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 19, 2010 NPUB
PUBLISHED FOR OPPOSITION
Jan 19, 2010 PUBO
LAW OFFICE PUBLICATION REVIEW COMPLETED
Dec 14, 2009 PREV
ASSIGNED TO LIE
Dec 14, 2009 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 30, 2009 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 7, 2009 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 6, 2009 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 6, 2009 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 12, 2009 GNRN
NON-FINAL ACTION E-MAILED
May 12, 2009 GNRT
NON-FINAL ACTION WRITTEN
May 12, 2009 CNRT
ASSIGNED TO EXAMINER
May 6, 2009 DOCK
NOTICE OF PSEUDO MARK MAILED
Mar 4, 2009 MPMK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 3, 2009 NWOS
NEW APPLICATION ENTERED
Mar 2, 2009 NWAP